↓ Skip to main content

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer

Overview of attention for article published in Frontiers in Medicine, December 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer
Published in
Frontiers in Medicine, December 2022
DOI 10.3389/fmed.2022.1070392
Pubmed ID
Authors

Joe M. O’Sullivan, Rana R. McKay, Kambiz Rahbar, Karim Fizazi, Daniel J. George, Bertrand Tombal, Anja Schmall, Per Sandström, Frank Verholen, Neal Shore

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2022.
All research outputs
#18,900,960
of 23,420,064 outputs
Outputs from Frontiers in Medicine
#4,184
of 6,005 outputs
Outputs of similar age
#298,144
of 434,865 outputs
Outputs of similar age from Frontiers in Medicine
#278
of 440 outputs
Altmetric has tracked 23,420,064 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,005 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,865 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 440 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.